Levey Andrew S, Greene Tom, Sarnak Mark J, Wang Xuelei, Beck Gerald J, Kusek John W, Collins Allan J, Kopple Joel D
Division of Nephrology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA.
Am J Kidney Dis. 2006 Dec;48(6):879-88. doi: 10.1053/j.ajkd.2006.08.023.
The long-term effect of a low-protein diet on the progression of chronic kidney disease is unknown. We evaluated effects of protein restriction on kidney failure and all-cause mortality during extended follow-up of the Modification of Diet in Renal Disease Study.
Study A was a randomized controlled trial from 1989 to 1993 of 585 patients with predominantly nondiabetic kidney disease and a moderate decrease in glomerular filtration rate (25 to 55 mL/min/1.73 m(2) [0.42 to 0.92 mL/s/1.73 m(2)]) assigned to a low- versus usual-protein diet (0.58 versus 1.3 g/kg/d). We used registries to ascertain the development of kidney failure (initiation of dialysis therapy or transplantation) or a composite of kidney failure and all-cause mortality through December 31, 2000. We used Cox regression models and intention-to-treat principles to compute hazard ratios for the low- versus usual-protein diet, adjusted for baseline glomerular filtration rate and other factors previously associated with the rate of decrease in glomerular filtration rate. We estimated hazard ratios for the entire follow-up period and then, in time-dependent analyses, separately for 2 consecutive 6-year periods of follow-up.
Kidney failure and the composite outcome occurred in 327 (56%) and 380 patients (65%), respectively. After adjustment for baseline factors, hazard ratios were 0.89 (95% confidence interval [CI], 0.71 to 1.12) and 0.88 (95% CI, 0.71 to 1.08), respectively. Adjusted hazard ratios for both outcomes were lower during the first 6 years (0.68; 95% CI, 0.51 to 0.93 and 0.66; 95% CI, 0.50 to 0.87, respectively) than afterward (1.27; 95% CI, 0.90 to 1.80 and 1.29; 95% CI, 0.94 to 1.78; interaction P = 0.008 and 0.002, respectively). Limitations include lack of data for dietary intake and clinical conditions after conclusion of the trial.
The efficacy of a 2- to 3-year intervention of dietary protein restriction on progression of nondiabetic kidney disease remains inconclusive. Future studies should include a longer duration of intervention and follow-up.
低蛋白饮食对慢性肾病进展的长期影响尚不清楚。我们在肾病饮食改良研究的长期随访中评估了蛋白质限制对肾衰竭和全因死亡率的影响。
研究A是一项1989年至1993年的随机对照试验,纳入了585例主要患有非糖尿病肾病且肾小球滤过率中度下降(25至55 mL/min/1.73 m²[0.42至0.92 mL/s/1.73 m²])的患者,将其分为低蛋白饮食组和常规蛋白饮食组(分别为0.58 g/kg/d和1.3 g/kg/d)。我们利用登记系统确定至2000年12月31日肾衰竭(开始透析治疗或移植)的发生情况,或肾衰竭与全因死亡率的复合情况。我们使用Cox回归模型和意向性分析原则来计算低蛋白饮食组与常规蛋白饮食组的风险比,并根据基线肾小球滤过率和其他先前与肾小球滤过率下降速率相关的因素进行调整。我们估计了整个随访期的风险比,然后在时间依赖性分析中,分别对连续两个6年随访期进行估计。
分别有327例(56%)和380例患者(65%)发生了肾衰竭和复合结局。在对基线因素进行调整后,风险比分别为0.89(95%置信区间[CI],0.71至1.12)和0.88(95%CI,0.71至1.08)。两种结局的调整后风险比在前6年(分别为0.68;95%CI,0.51至0.93和0.66;95%CI,0.50至0.87)均低于之后(分别为1.27;95%CI,0.90至1.80和1.29;95%CI,0.94至1.78;交互作用P值分别为0.008和0.002)。局限性包括试验结束后缺乏饮食摄入和临床状况的数据。
对非糖尿病肾病进展进行2至3年的饮食蛋白质限制干预的疗效仍不明确。未来的研究应包括更长时间的干预和随访。